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Spontaneous severe multivessel coronary artery vasospasm is a rare but important cause of morbidity. One-third of patients have
normal coronary vasculature, and these pose a signiﬁcant therapeutic dilemma as lack of clinical suspicion might potentially lead
to unnecessary revascularization therapies. A patient with resting chest pain and ischaemic electrocardiography demonstrated
severe coronary obstruction at catheter angiography. Preangioplasty further information highlighted spasm as the likely cause and
the angiographic abnormalities resolved post intracoronary nitrate. This paper emphasises thorough history-taking and judicious
use of nitrates during diagnostic coronary angiography in such patients. This may negate the need for more complex cardiac
interventions.
1.Introduction
Spontaneous coronary artery vasospasm is deﬁned as a
transient total or near-total occlusion of a vessel, occurring
in either a normal or diseased arterial segment, which is
reversible with isosorbide dinitrate [1]. It is an important
cause of morbidity, both in patients with proven coronary
artery disease and in those with “a variant form of angina
pectoris” as originally described by Prinzmetal et al. [2].
The latter typically is documented to present as chest pain
occurring at rest, rather than as a consequence of physical
exertion or emotional stress. Attacks of pain are observed to
be cyclical and more common in younger patients. Although
two-thirds of patients have concurrent atherosclerosis of a
major coronary artery, this is often mild or out of proportion
tothedegreeofsymptoms.Wereportacasewheremultifocal
coronary artery vasospasm was mistaken for obstructive
diﬀuse atherosclerosis and almost resulted in unnecessary
bypass grafting.
2. Case Presentation
A 50-year old Caucasian hypertensive exsmoker presented to
the Hareﬁeld Hospital primary angioplasty service in March
2007 with an acute exacerbation of longstanding anginal
c h e s tp a i na tr e s t .
Medical attention was not sought sooner, as the patient
had assumed that her symptoms were the consequence
of a putative chest infection for which she was taking
antibiotics. Other daily medication included appropriate
dosages of Clopidogrel, Dipyridamole, Ramipril and Nico-
randil and sublingual GTN. The latter had only marginally
improvedsymptoms.Onclinicalexamination,heartrateand
blood pressure were within normal limits, and auscultation
revealed normal heart sounds and diﬀuse expiratory pul-
monary wheeze.
The serum creatine kinase (CK-MB) was normal. How-
ever, the combination of a mildly raised serum cardiac
Troponin I (cTnI) of 1.1ng/ml and the presenting ECG
(Figure 1) necessitated the patient being prepared for pri-
mary angioplasty for inferolateral ST-elevation myocardial
infarction.
Selective coronary angiography demonstrated several
obstructive stenoses in the right and intermediate coronary
arteries (Figures 2(a)-2(b)). Complex intervention was con-
templated, and the patient was oﬀered angioplasty. At this
stage, the patient fortuitously revealed that she was told
she had unobstructed coronary arteries at angiography the2 Case Reports in Medicine
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Figure 1: Presenting electrocardiogram demonstrating presumed
ST-elevation myocardial infarction.
previous year. Multivessel coronary artery vasospasm was
now considered and intra-coronary nitroglycerin given. This
induced relief of chest pain marked attenuation of all visible
coronary stenoses (Figures 2(c)–2(d)) and resolution of ST
segment elevation.
The patient was discharged with complete relief of
symptoms and a normalization of the ECG on a regimen
of a regular oral nitrate and high-dose calcium antagonist
(Diltiazem).Thyroidfunction,vasoactiveintestinalpeptides,
and urinary catecholamine levels were all normal. No
primary cause for vasospasm was discovered.
3. Discussion
Coronary vasospasm is a transient abnormal contraction of
an epicardial coronary artery which can instigate myocardial
ischaemia [3]. The resultant spectrum of symptoms includes
angina, myocardial infarction, arrhythmia, and sudden
death. Although it can occur in vessel segments distressed
by atherosclerosis, traditionally it has been often associated
with variant or Prinzmetal’s angina. First described in 1959,
the latter is a syndrome where myocardial ischemia is
induced by cyclical chest pain, usually occurring at rest in
the early morning hours, and electrocardiographically most
commonly associated with dynamic ST-segment elevation
[2]. As in stable angina, the cardiac chest pain may be self-
limiting or (usually) relieved by nitrate medication. Our
case illustrates quite clearly that it is important that the
diagnosis of vasospasm is made correctly and as early as
possible. This may be hindered by the fact that the surface
ECG can be entirely normal between attacks. Serum cardiac
troponins also prove unreliable as they may or may not be
raised and in cases such as ours may be actively misleading.
The deﬁnitive diagnosis is made when angiographically
demonstrated coronary artery vasoconstriction reverses with
intravenous or intra-arterial nitroglycerin.
Patients with variant angina tend to be younger in
age than those with typical angina, and there is a relative
higher incidence in younger women and in those with a
systemic abnormality of vasomotor tone, such as suﬀerers
of migraine headache and Raynaud’s phenomenon [4, 5].
Theabsenceofriskfactorsforatheroscleroticcoronaryartery
disease suggests the diagnosis although cigarette smoking
is a common risk factor for both clinical syndromes. In
addition, racial heterogeneity probably exists in coronary
artery vasomotor reactivity since coronary vasospasm and
variantanginaaremoreprevalentintheJapanesepopulation
than in Caucasians [6]. Patients from the Far East may
exhibit a more diﬀuse abnormality of vasomotor tone, and
angiography may show segmental or diﬀuse coronary artery
spasm. In these populations, it appears that vasospasm is
more readily considered in the diﬀerential diagnosis in the
settingofacutechestpain.However,vasospasminCaucasian
patients raises treatment concerns. Beta-blockers are the ﬁrst
line therapy in patients with ischemic heart disease, angina
pectoris, or acute coronary syndrome in the Western world
but beta-blockade may aggravate coronary artery spasm
without the administration of calcium channel blocker or
nitrate.
The chest pain associated with variant angina is com-
monly severe and may be accompanied by palpitations or
syncope secondary to arrhythmia. It was originally believed
that the pain occurred at rest and that exercise tolerance was
characteristically normal in these individuals [2]. However,
there is increasing evidence that the pain exhibits a circadian
pattern, with most episodes occurring in the early hours of
themorning.Somestudieshaveshownthatmildsingle-stage
exercise is enough to induce variant angina in the early hours
of the morning whereas even vigorous multistage exercise
f a i l st od os oi nt h ea f t e r n o o n[ 3].
Thepathophysiologicalmechanismofvasospasticangina
is thought to centre around a dysfunctional vascular
endothelium[7].Normally,thevasculartoneoftheendothe-
lium is maintained by the interplay of vasorelaxing factors
(such as nitric oxide and prostacyclin) and vasoconstrictors
like endothelin-1. In the context of coronary vessels with a
normal endothelium, acetylcholine(Ach) stimulates release
of nitric oxide, which like external nitrates, should result in
coronary vasodilatation. However, in those with an impaired
endothelium, Ach fails to initiate release of nitric oxide and
its absence results in direct action of Ach on the vessel and
paradoxical vasoconstriction. In addition, nitric oxide also
has antiplatelet eﬀects and its lack compounds the problem
by the creation of a prothrombotic environment.
The most common cause of deranged endothelial func-
tion is in the setting of atherosclerosis. Historically, the
highest risk zones for acute coronary artery occlusion are
the proximal thirds of the vessels, and most incidences
of focal vasospasm occur at these regions [8]. There is
relatively greater plaque burden in the proximal thirds of
coronary arteries, and so it comes as no great surprise
that vasospasm is most prevalent at the site of coronary
atheromata. This may seem at odds with the ﬁndings in
our case, where the focal coronary spasm responded to
intravenous nitrate and the arteries were subsequently found
to appear normal. However, it is reported that vasospasm
in coronary vessels that seem normal on angiography may
have at least minimal atherosclerotic change not detected
by coronary angiography but detected by more sensitive
techniques such as intravascular ultrasonography [9].
Pharmacological ﬁrst-line management of coronary
vasospasm relies on drugs that promote direct vasodilatoryCase Reports in Medicine 3
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Figure 2: Selective Coronary Angiographic Images. Apparent stenoses in (a) intermediate and (b) right coronary arteries. Subsequent
attenuation of lesions in the (c) intermediate and (d) right coronary arteries following administration of intra-coronary nitrate.
eﬀects on the coronary vasculature. The most frequently
used are calcium channel blockers, alone or in combination
therapy with long-acting nitrates. By working synergistically
toabolishorlimitthevasoconstrictingeﬀectsofthedamaged
endothelium, they prevent vasospasm-induced ischaemia.
For those that are intolerant or refractory to these medi-
cations, the therapeutic options include administration of
selective alpha-adrenoceptor antagonists (prazosin) [10],
drugs that promote vasodilatation via the activation of
potassium channels (nicorandil) [11], or in the case of
diabetics, troglitazone may be eﬃcacious [12]. Revasculari-
sation therapies (percutaneous coronary artery intervention
or bypass grafting) have to be considered in the 20% of
patients that do not respond to medical treatment. One
should bear in mind however, that in up to one-third
of these patients coronary vasospasm can still be induced
at arterial segments not covered by the intervention [13,
14]. In patients with known atherosclerotic coronary artery
disease, meticulous attention should be paid to risk factor
modiﬁcation. Certainly the long-term survival and incidence
ofacutemyocardialinfarctionhavebeenshowntodependon
the degree of underlying coronaryarterydisease. Speciﬁcally,
there has been shown to be a correlation between the
extent of ﬁxed atherosclerotic thrombo-occlusive disease, the
degree of ST-elevation during acute episodes, the frequency
and duration of attacks, and the magnitude of ventricular
dysfunction [15].
4. Conclusion
Coronary artery vasospasm can cause a transient, abrupt,
and marked decrease in the diameter of an epicardial
coronary artery. Various aetiological mechanisms have been
implicated which are all probably related to an exagger-
ated contractile response of the vascular smooth muscle
in the aﬀected coronary vessels. Spasm usually aﬀects
atherosclerosis-aﬄicted segments in the coronary vascular
tree, but as in our case it may also occur in seemingly
angiographically normal arteries, albeit that subclinical
atherosclerotic change in such arteries may be detected by
more sensitive techniques such as intravascular ultrasonog-
raphy.
This paper illustrates the clinical importance of multi-
vessel coronary artery vasospasm in mimicking the angio-
graphic appearances of diﬀuse coronary atherosclerosis. It
exempliﬁes the importance of a detailed clinical history and
listening to the patient, because it may suggest the role
of dynamic vasomotor components. Administering intra-
coronary nitrate before embarking on angioplasty resulted
in the correct diagnosis, complete resolution of symptoms,4 Case Reports in Medicine
and the initiation of appropriate long-term therapy. Perhaps
more importantly, it prevented an unnecessary invasive
coronary procedure. Vasospasm should therefore always be
included in the diﬀerential diagnosis in suggestive presenta-
tions of acute coronary syndrome. We therefore suggest the
use of intra-coronary nitrate to be mandatory in all patients
with coronary stenosis or obstructions before considering
angioplasty to avoid the potential pitfall of inappropriate
coronary intervention.
Consent
Written informed consent was obtained from the patient for
publication of this case report and accompanying images.
A copy of the written consent is available for review by the
Editor-in-Chief of this journal.
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